Endometrial Carcinoma Immune Biomarkers and Prognostic Models from Cross-Study Analysis

A bioinformatics study by Jianhong Ma, last updated on 2026-05-29, systematically screens biomarkers and prognostic models associated with immune infiltration in endometrial carcinoma. The work identifies five immune-related markers and two gene families through cross-study analysis, validating their clinical prognostic significance. It is shared as a 106.3 KB DOCX document under a CC-BY-4.0 license on figshare.

Use Cases

• Validating prognostic models for endometrial carcinoma based on identified immune-related markers.
• Investigating oncogenic signaling pathways involved in tumor immune infiltration as described in the study.
• Identifying potential therapeutic targets based on the functional implications of immune infiltrating cells summarized in the document.

Strengths

• Identifies five specific immune-related markers and two gene families from cross-study analysis.
• Provides clinical prognostic validation for the identified markers.
• Document is 106.3 KB, making it a small, quickly downloadable resource.

Limitations

• The dataset is a 106.3 KB DOCX document, indicating a very limited scope and likely a summary document rather than raw data.
• Row count and column-level documentation are absent; data structure and semantics must be inferred after download.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

figshare, authored by Jianhong Ma.

Collection Method

Bioinformatics analysis building upon existing research, involving systematic screening and cross-study analysis.

Freshness

Last updated 2026-05-29 05:32:18; freshness should be verified.